Introduction
The design, the competencies inherent as well as the technologies present in the organisation are major factors that affect the overall operations of the organisation. In this regard, these factors tend to mesh together to form a type of organisation with a unique set of qualities. For instance, there are pharmaceutical companies that focus on the development of drugs to help diabetes patients. Diabetes, as of now, has yet to have a cure. All that is present in the market is a means to manage the illness. It is this reality that makes pharmaceutical companies to focus on their resources on diabetes. However, that is merely a speck of the overall reason why a certain pharmaceutical company prefers to focus on a single illness alone. The following discussion shall present these reasons.
The Task Variability in low
The development and manufacturing of these diabetes drugs are rather low in its task variability. Task variability, in its simplest sense, is the frequency of unexpected situations that an individual encounters while performing a particular task. In the case of the development and research in the said area, pharmaceutical companies tend to encounter considerably protracted periods before seeing some form of progress in their products. This means that in the development part alone, the variability of the task is low already. With reference to its manufacturing, the process is considerably routinely in nature which generally involves packaging and distribution of the merchandise. The quality of low task variability on the part of the pharmaceutical companies shows that the operations of these organisations are considerably easy to manage.
The Task Analysability is Low
Task analysability is the degree to which the search activity is needed to solve a problem. In this case, pharmaceutical companies have the propensity to encounter activities with low task analysability. This is because those charged by the company to find solutions to the diabetes problem will have to search for the solution for a protracted period of time. Their success or failure to do so is still vague. In the process, these individuals charged by pharmaceutical companies tend to stumble upon certain findings that don’t offer the cure for diabetes but gives the opportunity to manage the illness.
In the case of manufacturing the products, the company have some level of control on the task analysability. This is because they can programme it in advance. Failure on accomplishing the process comes from a breakdown of certain technologies in the company. Whether it is from the skills, knowledge, abilities, materials, machines, computers, tools and other equipment in the organisation, failure in the process will directly come from one of these elements.
The Production of the merchandise goes through routine manufacturing
While the development and research of the merchandise are non-routine, the production process in the pharmaceutical company is rather routine in nature. In having a routine manufacturing type of technology in the organisation means that it possesses low task variability and high analysability. This shows that the development and research process is more complex than that of the manufacturing. Essentially, the manufacturing part of the process involves mass production which is fundamentally a concrete manifestation of a routine manufacturing technology.
The Development of the product places high regard on craftswork technology
In the same regard, this shows that the research and development of the product involves craftswork as it has low task variability and low task analysability. Craftswork is considered a technology which concerns a selection of skilled workers who act together intimately to generate a set of custom designed products. For those involves in the research and development process, they tend to seek new methods of incorporating the existing methods to new situations. This is especially true in the case of the pharmaceutical industry where the standards of quality and competitive advantage among drugs and other medicines can change in a second.
The Organizational structure of Pharmaceutical Companies complements the Non-routine technology
The structure of the pharmaceutical company appears to be rather complex as its operations acquire both routine and non-routine technologies. This is the reason why the company focuses on a particular type of sickness, diabetes. It is assumed that such a company that does such a thing would have a considerably small structure. Whether the organisational structure is tall or small is still uncertain. However, the control on the overall organisation is distinctive with reference to the particular type of operation. On the part of the manufacturing functions, the company possess a high level of control while the research and development sector possesses some leeway as they would be taking into account the variability and analysability of the tasks involved in the process.
Conclusion
The discussions above have presented the reasons why a pharmaceutical company focuses on developing a diabetic medicine. First, one must point out that the operations of the company are complex as they manage both routine and non-routine technologies in its manufacturing and research and development functions respectively. The discussions show that the task variability and the task analysability of operating in such a manner are considerably low with reference to the research and development of the company. On the other hand, the company has immense control on the manufacturing side of their operations as the process acquires routine technologies which are highly predictable and manageable. The study found out that the research and development function of the pharmaceutical company provides higher esteem on craftswork while the manufacturing side acquires a routine manufacturing aspect of the technology. In any case, the structure of the company complements the overall function of focusing on a single type of illness. Focusing on other types may induce more resources which the company may fail to produce.
Credit:ivythesis.typepad.com
0 comments:
Post a Comment